SEC Filing Summary: Signal Genetics, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Signal Genetics, Inc. on May 26, 2016, reporting an event that occurred on May 25, 2016. The registrant is a Delaware corporation headquartered in Carlsbad, California. Note: The request metadata referenced "Viridian Therapeutics, Inc.," but the filing text explicitly identifies the registrant as Signal Genetics, Inc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes and Listing Status
On May 25, 2016, the Company received notification from the NASDAQ Listing Qualifications Department regarding a failure to meet the minimum bid price requirement of $1.00 per share for 30 consecutive business days under Listing Rule 5550(a)(2). The Company has been granted an additional 180 calendar days, until November 21, 2016, to regain compliance. The Company met all other initial listing requirements, including the market value of publicly-traded shares.
Outlook, Risks, and Contingencies
- Compliance Path: To regain compliance, the Company must maintain a closing bid price of at least $1.00 per share for 10 consecutive business days at any time during the extension period.
- Reverse Stock Split: If the Company opts to implement a reverse stock split, it must be completed no later than ten business days prior to November 21, 2016.
- Delisting Risk: Failure to regain compliance by November 21, 2016, will result in written notification that the common stock may be delisted.
- Appeal Process: The Company may appeal a delisting determination to a NASDAQ Hearings Panel. The stock would remain listed pending the Panel's decision, though there is no assurance of a successful appeal.
Investor Verification Checklist
- Verify the current closing bid price of Signal Genetics, Inc. common stock to assess proximity to the $1.00 threshold.
- Monitor press releases for announcements regarding a potential reverse stock split before the October 2016 deadline.
- Review subsequent filings to confirm if the Company achieved 10 consecutive days of compliance or if a delisting notice was issued after November 21, 2016.
- Confirm the Company's cash position and ability to fund operations if delisted, as this filing does not disclose liquidity metrics.